Renaissance Group LLC Collegium Pharmaceutical, Inc Transaction History

Renaissance Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$17.5 - $21.35 $824,950 - $1.01 Million	-47,140 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$17.75 - $25.39 $11,040 - $15,792	-622 Reduced 1.3%	47,140 $931,000
Q2 2021 Aug 13, 2021	BUY	$21.74 - $25.28 $224,248 - $260,763	10,315 Added 27.55%	47,762 $1.13 Million
Q1 2021 May 13, 2021	BUY	$19.25 - $26.1 $4,254 - $5,768	221 Added 0.59%	37,447 $887,000
Q4 2020 Feb 12, 2021	BUY	$17.83 - $22.29 $16,760 - $20,952	940 Added 2.59%	37,226 $746,000
Q3 2020 Nov 12, 2020	SELL	$15.78 - $20.82 $3,708 - $4,892	-235 Reduced 0.64%	36,286 $755,000
Q2 2020 Aug 12, 2020	BUY	$15.49 - $23.51 $4,631 - $7,029	299 Added 0.83%	36,521 $639,000
Q1 2020 May 06, 2020	BUY	$13.89 - $25.45 $14,403 - $26,391	1,037 Added 2.95%	36,222 $592,000
Q4 2019 Feb 12, 2020	BUY	$10.7 - $22.24 $376,479 - $782,514	35,185 New	35,185 $724,000

247

37.4M

59.3K

9.5K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.01B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Group LLC with notifications on news.